(Q41012972)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967905%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

review article

1 reference

title

Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967905%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

main subject

mucosal immune system

1 reference

R P MacDermott

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967905%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 November 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967905%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967905%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967905%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

1207-1231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967905%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967905%20AND%20SRC:MED&resulttype=core&format=json

Enhanced local production of complement components in the small intestines of patients with Crohn's disease

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Effect of Prostaglandin E2 on Adjuvant Arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Immune status in Crohn's disease : 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Immune status in Crohn's disease. I. Leukocyte and lymphocyte subpopulations in peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Mediators of anaphylaxis and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Local immunity in ulcerative colitis: evidence for defective secretory IgA production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Pinocytosis by epithelium associated with lymphoid follicles in the bursa of fabricius, appendix, and Peyer's patches. An electron microscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Lymphoepithelial interactions in the mucosal immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

CH Isotype 'Switching' During Normal B-Lymphocyte Development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Interleukin-1 in the pathogenesis of and protection from inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

The depression of phagocytosis by exogenous cyclic nucleotides, prostaglandins, and theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Suppression of human polymorphonuclear function after intravenous infusion of prostaglandin E1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Antiarthritic and Antiinflammatory Effects of Certain Prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Assay of prostaglandin-like substances in faeces and their measurement in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Studies of prostaglandins and sulphasalazine in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Complement-mediated release of histamine from human basophils *1, *2III. Possible regulatory role of microtubules and microfilaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Heterogeneity of B Cells: Direct Evidence of Selective Triggering of Distinct Subpopulations by Polyclonal Activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Complement activation requirements for histamine release from human leukocytes: influence of purified C3ahu and C5ahu on histamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Evidence that prednisolone is inhibitory to the cyclooxygenase activity of human rectal mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Significance of immunoglobulin G subclasses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Homing receptors and the control of lymphocyte migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Polyclonal nature of the intestinal mucosal lymphocyte populations in inflammatory bowel disease. A molecular genetic evaluation of the immunoglobulin and T-cell antigen receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. I. T cells derived from Peyer's patches that switch sIgM B Cells to sIgA B cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. II. Terminal differentiation of postswitch sIgA-bearing Peyer's patch B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Correlation of histopathologic evidence of disease activity with the presence of immunoglobulin-containing cells in the colons of patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Suppression of immune complex vasculitis in rats by prostaglandin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: Studies in a model of tissue-bound IgG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Letter: Rectal bleeding and indomethacin suppositories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Inhibition of antibody secretion by 5-aminosalicylic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Decreased expression of HLA-DR antigens on peripheral blood B lymphocytes during glucocorticoid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

The common mucosal immune system and current strategies for induction of immune responses in external secretions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Immunoglobulin G (IgG) subclasses and human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Normal human intestinal B lymphocytes. Increased activation compared with peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Assessment of inflammatory bowel disease activity by technetium 99m phagocyte scanning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Prostaglandin synthesis inhibitors in ulcerative colitis: Flurbiprofen compared with conventional treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Immunoglobulin containing cells in inflammatory bowel disease of the colon: a morphometric and immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Granulocyte migration in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Rectal mucosal plasma cells in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

T lymphocyte subsets in inflammatory bowel disease: peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Motility and adhesiveness in human neutrophils. Effects of chemotactic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Prostaglandins modulate macrophage Ia expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

A tissue-specific endothelial cell molecule involved in lymphocyte homing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Biosynthesis and biological activity of leukotriene B5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

The basis for the immunoregulatory role of macrophages and other accessory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Immunoglobulin A: strategic defense initiative at the mucosal surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

A quantitative study of immunoglobulin containing cells in the differential diagnosis of acute colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Disorders of B cells and helper T cells in the pathogenesis of the immunoglobulin deficiency of patients with ataxia telangiectasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Intestinal M Cells: A Pathway for Entry of Reovirus into the Host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Studies of human C5a as a mediator of inflammation in normal human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Suppression of acute and chronic inflammation in adrenalectomized rats by pharmacologic amounts of prostaglandins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

Immunohistological studies of surface antigen on colonic lymphoid cells in normal and inflamed mucosa. Comparison of follicular and lamina propria lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

7 January 2021

Expression of human immunoglobulin G subclasses in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

7 January 2021

Alterations of the immune system in ulcerative colitis and Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

7 January 2021

Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

7 January 2021

Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

7 January 2021

Interleukin-6 and its receptor are expressed in human intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930096-7

7 January 2021

10.1016/S0025-7125(16)30096-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7967905%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference